BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chitranshi N, Dheer Y, Mirzaei M, Wu Y, Salekdeh GH, Abbasi M, Gupta V, Vander Wall R, You Y, Graham SL, Gupta V. Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection. Mol Ther 2019;27:424-41. [PMID: 30341011 DOI: 10.1016/j.ymthe.2018.09.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Askari S, Azizi F, Javadpour P, Karimi N, Ghasemi R. Endoplasmic reticulum stress as an underlying factor in leading causes of blindness and potential therapeutic effects of 4-phenylbutyric acid: from bench to bedside. Expert Review of Ophthalmology 2022. [DOI: 10.1080/17469899.2022.2145945] [Reference Citation Analysis]
2 Li Y, Jin K, Xiang M. Optic nerve repair and regeneration in vertebrates. Sci Sin -Vitae 2022;52:988-1005. [DOI: 10.1360/ssv-2021-0094] [Reference Citation Analysis]
3 Zhu J, Zou J, Li F, Gao Y, Wang L, Sun Y, Zhu J, Zhang X, Xue K, Li G, Cheng NM, Guo J, Zhang X, Zhang K. Evaluation of neuroprotective agents acting via the BDNF–TrkB pathway using AI‐enabled predictions of ligand–receptor interactions. MedComm – Future Medicine 2022;1. [DOI: 10.1002/mef2.15] [Reference Citation Analysis]
4 Lambuk L, Mohd Lazaldin MA, Ahmad S, Iezhitsa I, Agarwal R, Uskoković V, Mohamud R. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Front Pharmacol 2022;13:875662. [DOI: 10.3389/fphar.2022.875662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gupta V, Chitranshi N, Gupta V, You Y, Rajput R, Paulo JA, Mirzaei M, van den Buuse M, Graham SL. TrkB receptor agonist 7,8 dihydroxyflavone is protective against the inner retinal deficits induced by experimental glaucoma. Neuroscience 2022:S0306-4522(22)00034-3. [PMID: 35217121 DOI: 10.1016/j.neuroscience.2022.01.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Geva M, Gershoni-Emek N, Naia L, Ly P, Mota S, Rego AC, Hayden MR, Levin LA. Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma. Sci Rep 2021;11:21975. [PMID: 34753986 DOI: 10.1038/s41598-021-01077-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, Saks D, Hasan M, Amirkhani A, McKay M, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M. A Proteomic View of Cellular and Molecular Effects of Cannabis. Biomolecules 2021;11:1411. [PMID: 34680044 DOI: 10.3390/biom11101411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Yoganathan S, Arunachal G, Gowda VK, Vinayan KP, Thomas M, Whitney R, Jain P. NTRK2-related developmental and epileptic encephalopathy: Report of 5 new cases. Seizure 2021;92:52-5. [PMID: 34425480 DOI: 10.1016/j.seizure.2021.08.008] [Reference Citation Analysis]
9 Guo X, Zhou J, Starr C, Mohns EJ, Li Y, Chen EP, Yoon Y, Kellner CP, Tanaka K, Wang H, Liu W, Pasquale LR, Demb JB, Crair MC, Chen B. Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell 2021;184:4299-4314.e12. [PMID: 34297923 DOI: 10.1016/j.cell.2021.06.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
10 Lu S, Peng X, Lin G, Xu K, Wang S, Qiu W, Du H, Chang K, Lv Y, Liu Y, Deng H, Hu C, Xu X. Grass carp (Ctenopharyngodon idellus) SHP2 suppresses IFN I expression via decreasing the phosphorylation of GSK3β in a non-contact manner. Fish Shellfish Immunol 2021;116:150-60. [PMID: 34265416 DOI: 10.1016/j.fsi.2021.07.005] [Reference Citation Analysis]
11 Li J, Xiao L, Yan N, Li Y, Wang Y, Qin X, Zhao D, Liu M, Li N, Lin Y. The Neuroprotective Effect of MicroRNA‐22‐3p Modified Tetrahedral Framework Nucleic Acids on Damaged Retinal Neurons Via TrkB/BDNF Signaling Pathway. Adv Funct Mater 2021;31:2104141. [DOI: 10.1002/adfm.202104141] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 22.0] [Reference Citation Analysis]
12 Le YZ, Xu B, Chucair-Elliott AJ, Zhang H, Zhu M. VEGF Mediates Retinal Müller Cell Viability and Neuroprotection through BDNF in Diabetes. Biomolecules 2021;11:712. [PMID: 34068807 DOI: 10.3390/biom11050712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Huang R, Xu Y, Lu X, Tang X, Lin J, Cui K, Yu S, Shi Y, Ye D, Liu Y, Liang X. Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. J Pineal Res 2021;71:e12716. [PMID: 33426650 DOI: 10.1111/jpi.12716] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
14 Abbasi M, Gupta VK, Chitranshi N, Gupta V, Ranjbaran R, Rajput R, Pushpitha K, Kb D, You Y, Salekdeh GH, Parton RG, Mirzaei M, Graham SL. Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner. Theranostics 2021;11:6154-72. [PMID: 33995651 DOI: 10.7150/thno.55472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Samelska K, Zaleska-Żmijewska A, Bałan B, Grąbczewski A, Szaflik JP, Kubiak AJ, Skopiński P. Immunological and molecular basics of the primary open angle glaucoma pathomechanism. Cent Eur J Immunol 2021;46:111-7. [PMID: 33897292 DOI: 10.5114/ceji.2021.104328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Sharma DS, Wadhwa S, Gulati M, Kadukkattil Ramanunny A, Awasthi A, Singh SK, Khursheed R, Corrie L, Chitranshi N, Gupta VK, Vishwas S. Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy. Expert Opin Drug Deliv 2021;18:553-76. [PMID: 33143473 DOI: 10.1080/17425247.2021.1846518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Mostinski Y, Heynen GJJE, López-Alberca MP, Paul J, Miksche S, Radetzki S, Schaller D, Shanina E, Seyffarth C, Kolomeets Y, Ziebart N, de Schryver J, Oestreich S, Neuenschwander M, Roske Y, Heinemann U, Rademacher C, Volkamer A, von Kries JP, Birchmeier W, Nazaré M. From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. J Med Chem 2020;63:14780-804. [PMID: 33210922 DOI: 10.1021/acs.jmedchem.0c01265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
18 Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, Basavarajappa D, Godinez A, Di Angelantonio S, Sachdev P, Salekdeh GH, Bouwman F, Graham S, Gupta V. Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res 2021;82:100899. [PMID: 32890742 DOI: 10.1016/j.preteyeres.2020.100899] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
19 Joseph C, Mangani AS, Gupta V, Chitranshi N, Shen T, Dheer Y, Kb D, Mirzaei M, You Y, Graham SL, Gupta V. Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development. Aging Dis 2020;11:946-66. [PMID: 32765956 DOI: 10.14336/AD.2019.0923] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
20 Mirzaei M, Gupta VK, Chitranshi N, Deng L, Pushpitha K, Abbasi M, Chick JM, Rajput R, Wu Y, McKay MJ, Salekdeh GH, Gupta VB, Haynes PA, Graham SL. Retinal proteomics of experimental glaucoma model reveal intraocular pressure-induced mediators of neurodegenerative changes. J Cell Biochem 2020. [PMID: 32692886 DOI: 10.1002/jcb.29822] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
21 Abbasi M, Gupta VK, Chitranshi N, Gupta VB, Mirzaei M, Dheer Y, Garthwaite L, Zaw T, Parton RG, You Y, Graham SL. Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation. Mol Neurobiol 2020;57:3759-84. [PMID: 32578008 DOI: 10.1007/s12035-020-01948-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 Mirzaei M, Gupta V, Chitranshi N, Deng L, Pushpitha K, Abbasi M, Chick J, Rajput R, Wu Y, Mckay MJ, Salekdeh GH, Gupta V, Haynes PA, Graham SL. Experimental glaucoma retinal proteomics identifies mutually exclusive and overlapping molecular characteristics with human glaucoma.. [DOI: 10.1101/2020.05.14.095307] [Reference Citation Analysis]
23 Chiha W, Bartlett CA, Petratos S, Fitzgerald M, Harvey AR. Intravitreal application of AAV-BDNF or mutant AAV-CRMP2 protects retinal ganglion cells and stabilizes axons and myelin after partial optic nerve injury. Exp Neurol 2020;326:113167. [PMID: 31904385 DOI: 10.1016/j.expneurol.2019.113167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
24 Deng L, Pushpitha K, Joseph C, Gupta V, Rajput R, Chitranshi N, Dheer Y, Amirkhani A, Kamath K, Pascovici D, Wu JX, Salekdeh GH, Haynes PA, Graham SL, Gupta VK, Mirzaei M. Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells. Front Mol Neurosci 2019;12:24. [PMID: 30853886 DOI: 10.3389/fnmol.2019.00024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
25 Mirzaei M, Pushpitha K, Deng L, Chitranshi N, Gupta V, Rajput R, Mangani AB, Dheer Y, Godinez A, McKay MJ, Kamath K, Pascovici D, Wu JX, Salekdeh GH, Karl T, Haynes PA, Graham SL, Gupta VK. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease. Mol Neurobiol 2019;56:6017-34. [PMID: 30707393 DOI: 10.1007/s12035-019-1479-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]